Multi-omics integration reveals BPGM downregulation and potential plasma metabolite biomarkers for childhood asthma - Scorecard - MDSpire

Multi-omics integration reveals BPGM downregulation and potential plasma metabolite biomarkers for childhood asthma

  • By

  • Junlin Zhao

  • Zhiyuan Wang

  • Yanan Wang

  • Qianqian Dai

  • Menghua Li

  • Aliya Maimaitiniyazi

  • Zhenzhen Guo

  • Liang Ru

  • May 7, 2026

  • 0 min

Share

Clinical Scorecard: Integration of Multi-Omics Data Identifies BPGM Downregulation and Possible Plasma Metabolite Biomarkers in Pediatric Asthma

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationTreatment-naive, normal-weight children aged 6–14 years with asthma
Care Setting

Key Highlights

  • additional_info

Guideline-Based Recommendations

Diagnosis

  • C
  • i
  • t
  • e
  • s
  • p
  • e
  • c
  • i
  • f
  • i
  • c
  • s
  • t
  • u
  • d
  • i
  • e
  • s
  • o
  • r
  • g
  • u
  • i
  • d
  • e
  • l
  • i
  • n
  • e
  • s
  • f
  • o
  • r
  • 5
  • -
  • a
  • m
  • i
  • n
  • o
  • l
  • e
  • v
  • u
  • l
  • i
  • n
  • i
  • c
  • a
  • c
  • i
  • d
  • .

Management

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Discuss potential outcomes of precision medicine approaches.

        Clinical Best Practices

        • methodologies

        Related Resources & Content

        Original Source(s)

        Multi-omics integration reveals BPGM downregulation and potential plasma metabolite biomarkers for childhood asthma

        • by Junlin Zhao, Zhiyuan Wang, Yanan Wang, Qianqian Dai, Menghua Li, Aliya Maimaitiniyazi, Zhenzhen Guo, Liang Ru

        • May 7, 2026

        Related Content

        Restraint care in the pediatric intensive care unit: a qualitative investigation of nurses’ perspectives and experiences

        Usefulness of ultrasound in diagnosing constipation in children: a narrative review

        Isoflurane for difficult sedation in critically ill children: a retrospective analysis in a mixed pediatric intensive care population